Professor Henry Woo

Professor Henry Woo is a urological surgeon specialising in surgery of the prostate.

Henry Woo is a urological surgeon sub-specialising in surgery of the prostate. He cares for men with suspected or already diagnosed prostate cancer as well as men with urinary complaints. He has both a national and international reputation for his work in the area of prostate disease. Appointments to see Henry Woo are made by calling 02-9473 8765 or alternatively, email to front desk@urologist.net. au A search on Dr Google will reveal a large volume of information about his academic and professional standing. He does not believe in aggressive self promotion, as the best advertisement for his services are his former and current patients. He does not believe in embellishment of his credentials by saying he is the best, the first, the most etc as these statements have little relationship to ability and empathy as an expert surgeon.

He is a Professor of Surgery at the Sydney Adventist Hospital Clinical School of the University of Sydney. He is also the Director of Uro-oncology and the Professor of Robotic Cancer Surgery at the Chris O'Brien Lifehouse. He consults and operates at both the Sydney Adventist Hospital and the Chris O'Brien Lifehouse. In the past he was a urological surgeon at Westmead Public Hospital for approximately 18 years and had also worked as a visiting urologist to Moree District Hospital.

He has a strong record of academic pursuit. He has published over 150 peer reviewed papers and several book chapters (RG score 45 and h-index 30). He is on the Executive Committee of the Asian Pacific Prostate Society (APPS) and is on the Editorial Board of a number of journals including European Urology, BJUI, Asian Journal of Urology, Prostate International, Prostate Cancer Prostatic Diseases and World Journal of Men's Health. He is an Associate Editor of Prostate Cancer Prostate Diseases journal (IF 2014 = 3. 425) and was the foundation Editor in Chief of BJUI Knowledge. He is a peer reviewer for all of the major urolgoical journals.

He is passionate about clinical trials and is a Board Director of the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP). He is also a Board Director of the Australasian Urological Foundation (AUF) which is a charitable organisation supporting research in the field of urology.